Kyverna Therapeutics Inc.

2.16
0.03 (1.41%)
At close: Apr 24, 2025, 3:59 PM
2.04
-5.56%
Pre-market: Apr 25, 2025, 08:47 AM EDT

Kyverna Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
-37.49M -34.49M -28.8M -26.69M -20.67M -15.46M -13.09M -11.14M -8.5M
563K 558K 530K 482K 462K 438K 413K 394K 374K
1.38M 3.41M 1.28M 2.28M 784K 521K 447K 468K 337K
5.33M -4.88M 6.51M -4.91M -1.97M 2.86M n/a -1.59M -282K
-1.55M 2.85M -1.59M 526K 454K 892K 438K 384K 419K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
34K 186K 4.41M -1.84M 1.01M 3.37M 528K -1.48M -1.31M
-37.06M -27.49M -24.18M -25.52M -18.56M -11.13M -11.26M -11.46M -8.82M
-532K -102K -1.03M -543K -334K -256K -3K -28K -12K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
-127.25M -137.52M -79.89M -145.34M -985K -53.86M n/a n/a -1.44M
157M 132.87M 13M 23M 33M n/a n/a 13.68M 16.6M
n/a 5.43M n/a -122.34M 32.02M n/a n/a 13.68M 15.16M
29.22M 676K -67.92M -122.88M 31.68M -54.12M -3K 13.65M 15.15M
-247K -242K -236K -231K -219K -205K -189K -168K -145K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
32K 90K -333K -2.89M -1.22M 154K 25.09M 24K 43K
-215K -152K -569K 338.05M -1.43M 34.79M 24.91M -144K -102K
-8.05M -26.96M -92.67M 189.65M 11.68M -30.46M 13.65M 2.05M 6.23M
-37.59M -27.59M -25.2M -26.07M -18.9M -11.39M -11.26M -11.49M -8.83M